Literature DB >> 19030729

Occult hepatitis B virus infection in immunocompromised patients.

Ruth Nogueira Cordeiro Moraes Jardim1, Neiva Sellan Lopes Gonçales, Josiane Silveira Felix Pereira, Viviane Cristina Fais, Fernando Lopes Gonçales Junior.   

Abstract

Occult hepatitis B infection is characterized by hepatitis B virus (HBV) DNA in the serum in the absence of hepatitis B surface antigen (HBsAg). We assessed occult HBV infection prevalence in two groups of immunocompromised patients (maintenance hemodialysis patients and HIV-positive patients) presenting HBsAg-negative and anti-HBc positive serological patterns, co-infected or not by HCV. Thirty-four hemodialysis anti-HIV negative patients, 159 HIV-positive patients and 150 blood donors who were anti-HBc positive (control group) were selected. HBV-DNA was detected by nested-PCR. Occult hepatitis B infection was not observed in the hemodialysis patients group but was found in 5% of the HIV-patients and in 4% of the blood donors. Immunosuppression in HIV positive patients was not a determining factor for occult HBV infection. In addition, no significant relationship between HBV-DNA and HCV co-infection in the HIV-positive patient group was found. A lack of significant associations was also observed between positivity for HBV-DNA and CD4 count, viral load and previous lamivudine treatment in these HIV-positive patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19030729     DOI: 10.1590/s1413-86702008000400008

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  13 in total

Review 1.  Occult hepatitis B virus co-infection in human immunodeficiency virus-positive patients: A review of prevalence, diagnosis and clinical significance.

Authors:  Angelica Maldonado-Rodriguez; Ana Maria Cevallos; Othon Rojas-Montes; Karina Enriquez-Navarro; Ma Teresa Alvarez-Muñoz; Rosalia Lira
Journal:  World J Hepatol       Date:  2015-02-27

2.  Molecular analysis of hepatitis B virus (HBV) in an HIV co-infected patient with reactivation of occult HBV infection following discontinuation of lamivudine-including antiretroviral therapy.

Authors:  Andrea Costantini; Katia Marinelli; Giulia Biagioni; Alessia Monachetti; Monica L Ferreri; Luca Butini; Maria Montroni; Aldo Manzin; Patrizia Bagnarelli
Journal:  BMC Infect Dis       Date:  2011-11-04       Impact factor: 3.090

3.  Longitudinal evaluation of occult hepatitis B infection in HIV-1 infected individuals during highly active antiretroviral treatment interruption and after HAART resumption.

Authors:  S Bagaglio; G Bianchi; A Danise; L Porrino; C Uberti-Foppa; A Lazzarin; A Castagna; G Morsica
Journal:  Infection       Date:  2011-03-22       Impact factor: 3.553

Review 4.  Clinical significance of occult hepatitis B virus infection.

Authors:  Miriam Romero; Antonio Madejón; Conrado Fernández-Rodríguez; Javier García-Samaniego
Journal:  World J Gastroenterol       Date:  2011-03-28       Impact factor: 5.742

Review 5.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

6.  Prevalence of Occult Hepatitis B Virus Infection in Hemodialysis Patients Using Nested PCR.

Authors:  Elham Samadi; Hessam Mirshahabi; Nima Motamed; Hamid Sadeghi
Journal:  Rep Biochem Mol Biol       Date:  2020-04

Review 7.  Clinical impact of occult hepatitis B virus infection in immunosuppressed patients.

Authors:  Evangelista Sagnelli; Mariantonietta Pisaturo; Salvatore Martini; Pietro Filippini; Caterina Sagnelli; Nicola Coppola
Journal:  World J Hepatol       Date:  2014-06-27

Review 8.  Clinical implications of hepatitis B virus mutations: recent advances.

Authors:  Ivana Lazarevic
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

9.  Occult hepatitis B virus infection among Mexican human immunodeficiency virus-1-infected patients.

Authors:  Ma Teresa Alvarez-Muñoz; Angelica Maldonado-Rodriguez; Othon Rojas-Montes; Rocio Torres-Ibarra; Fernanda Gutierrez-Escolano; Guillermo Vazquez-Rosales; Alejandro Gomez; Onofre Muñoz; Javier Torres; Rosalia Lira
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

10.  Polymorphisms within Fas gene are not associated with occult hepatitis B virus infection: Polymorphisms within Fas gene in occult HBV infection.

Authors:  Mohammad Kazemi Arababadi; Adel Mohammadzadeh; Ali Akbar Pourfathollah; Derek Kennedy
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.